A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis

NCT01452685 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

397

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: Placebo
DRUG: TAK-385
DRUG: TAK-385
DRUG: TAK-385
DRUG: Leuprorelin acetate

Sponsor

Takeda